Harmony Biosciences Holdings, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
65.88
|
|
Average Rating
|
4.38
|
|
# Strong Buys
|
4
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.13
|
1.44
|
1.31
|
1007.69%
|
|
2022-06-30
|
0.44
|
0.39
|
-0.05
|
-11.36%
|
|
2022-03-31
|
0.29
|
0.35
|
0.06
|
20.69%
|
|
2021-12-31
|
0.36
|
0.38
|
0.02
|
5.56%
|
|
2021-09-30
|
0.29
|
-0.17
|
-0.46
|
-158.62%
|
|
2021-06-30
|
0.18
|
0.24
|
0.06
|
33.33%
|
|
2021-03-31
|
-0.03
|
0.13
|
0.16
|
533.33%
|
|
2020-12-31
|
0.09
|
0.25
|
0.16
|
177.78%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
2.18
|
|
2021-12-31
|
0.58
|
|
2020-12-31
|
-2.82
|